These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32723157)

  • 1. The CCNY (cyclin Y)-CDK16 kinase complex: a new regulator of autophagy downstream of AMPK.
    Vervoorts J; Neumann D; Lüscher B
    Autophagy; 2020 Sep; 16(9):1724-1726. PubMed ID: 32723157
    [No Abstract]   [Full Text] [Related]  

  • 2. New tricks of an old autophagy regulator: AMPK-dependent regulation of autophagy through CCNY (cyclin Y)-CDK16.
    Gatica D; Klionsky DJ
    Autophagy; 2020 Jun; 16(6):973-974. PubMed ID: 32401167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK-dependent activation of the Cyclin Y/CDK16 complex controls autophagy.
    Dohmen M; Krieg S; Agalaridis G; Zhu X; Shehata SN; Pfeiffenberger E; Amelang J; Bütepage M; Buerova E; Pfaff CM; Chanda D; Geley S; Preisinger C; Sakamoto K; Lüscher B; Neumann D; Vervoorts J
    Nat Commun; 2020 Feb; 11(1):1032. PubMed ID: 32098961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 16/PCTAIRE kinase 1 is activated by cyclin Y and is essential for spermatogenesis.
    Mikolcevic P; Sigl R; Rauch V; Hess MW; Pfaller K; Barisic M; Pelliniemi LJ; Boesl M; Geley S
    Mol Cell Biol; 2012 Feb; 32(4):868-79. PubMed ID: 22184064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse.
    Zi Z; Zhang Z; Li Q; An W; Zeng L; Gao D; Yang Y; Zhu X; Zeng R; Shum WW; Wu J
    PLoS Genet; 2015 Aug; 11(8):e1005485. PubMed ID: 26305884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orphan kinases turn eccentric: a new class of cyclin Y-activated, membrane-targeted CDKs.
    Mikolcevic P; Rainer J; Geley S
    Cell Cycle; 2012 Oct; 11(20):3758-68. PubMed ID: 22895054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16.
    Dixon-Clarke SE; Shehata SN; Krojer T; Sharpe TD; von Delft F; Sakamoto K; Bullock AN
    Biochem J; 2017 Feb; 474(5):699-713. PubMed ID: 28057719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex.
    Hernández-Ortega S; Sánchez-Botet A; Quandt E; Masip N; Gasa L; Verde G; Jiménez J; Levin RS; Rutaganira FU; Burlingame AL; Wolfgeher D; Ribeiro MPC; Kron SJ; Shokat KM; Clotet J
    Exp Mol Med; 2019 Apr; 51(4):1-17. PubMed ID: 30992425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3 Binding to Cyclin Y contributes to cyclin Y/CDK14 association.
    Li S; Jiang M; Wang W; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2014 Apr; 46(4):299-304. PubMed ID: 24618387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin Y phosphorylation- and 14-3-3-binding-dependent activation of PCTAIRE-1/CDK16.
    Shehata SN; Deak M; Morrice NA; Ohta E; Hunter RW; Kalscheuer VM; Sakamoto K
    Biochem J; 2015 Aug; 469(3):409-20. PubMed ID: 26205494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of cyclin Y by CDK14 induces its ubiquitination and degradation.
    Li S; Song W; Jiang M; Zeng L; Zhu X; Chen J
    FEBS Lett; 2014 May; 588(11):1989-96. PubMed ID: 24794231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cyclin Y in normal and pathological cells.
    Opacka A; Żuryń A; Krajewski A; Mikołajczyk K
    Cell Cycle; 2023 Apr; 22(8):859-869. PubMed ID: 36576166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma.
    Sun T; Co NN; Wong N
    Biochem Biophys Res Commun; 2014 Jun; 449(1):163-8. PubMed ID: 24824184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel PCTAIRE-1/CDK16 substrates using a chemical genetic screen.
    Shehata SN; Deak M; Collodet C; Spiegl SF; Geley S; Sumpton D; Sakamoto K
    Cell Signal; 2019 Jul; 59():53-61. PubMed ID: 30880224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinating cell cycle progression via cyclin specificity.
    Pagliuca FW; Collins MO; Choudhary JS
    Cell Cycle; 2011 Dec; 10(24):4195-6. PubMed ID: 22156915
    [No Abstract]   [Full Text] [Related]  

  • 17. Discovery of 3-Amino-1
    Amrhein JA; Berger LM; Tjaden A; Krämer A; Elson L; Tolvanen T; Martinez-Molina D; Kaiser A; Schubert-Zsilavecz M; Müller S; Knapp S; Hanke T
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ik3-1/Cables is a substrate for cyclin-dependent kinase 3 (cdk 3).
    Yamochi T; Semba K; Tsuji K; Mizumoto K; Sato H; Matsuura Y; Nishimoto I; Matsuoka M
    Eur J Biochem; 2001 Dec; 268(23):6076-82. PubMed ID: 11733001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles, molecular interactions, and therapeutic value of CDK16 in human cancers.
    Wang X; Liu R; Li S; Xia W; Guo H; Yao W; Liang X; Lu Y; Zhang H
    Biomed Pharmacother; 2023 Aug; 164():114929. PubMed ID: 37236028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of AMP-activated protein kinase in cancer therapy.
    Rehman G; Shehzad A; Khan AL; Hamayun M
    Arch Pharm (Weinheim); 2014 Jul; 347(7):457-68. PubMed ID: 24677093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.